We are live on ! Find out more
PALI icon

Palisade Bio
PALI

5 hedge funds and large institutions have $1.21M invested in Palisade Bio in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% more ownership

Funds ownership: 7.42% → 7.49% (+0.07%)

0% more funds holding

Funds holding: 5 → 5 (0)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PALI Hedge Fund Activity: Q3 2018 in Review

5 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2018, worth a combined $1.21M — down 3.6% from $1.26M a quarter earlier.

Fund positioning in PALI was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held Palisade Bio (PALI) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $1.21M of Palisade Bio stock for Q3 2018, down 3.6% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q3 2018 and 0 closed out.

Based on aggregated 13F filings for Q3 2018.